UFP TECHNOLOGIES INC (UFPT) Stock Fundamental Analysis
NASDAQ:UFPT - Nasdaq - US9026731029 - Common Stock - Currency: USD
We assign a fundamental rating of 6 out of 10 to UFPT. UFPT was compared to 187 industry peers in the Health Care Equipment & Supplies industry. UFPT scores excellent on profitability, but there are some minor concerns on its financial health. UFPT is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes UFPT very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year UFPT was profitable.
In the past year UFPT had a positive cash flow from operations.
UFPT had positive earnings in each of the past 5 years.
Each year in the past 5 years UFPT had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 9.88%, UFPT belongs to the best of the industry, outperforming 93.05% of the companies in the same industry.
The Return On Equity of UFPT (17.60%) is better than 91.98% of its industry peers.
Looking at the Return On Invested Capital, with a value of 13.23%, UFPT belongs to the top of the industry, outperforming 95.19% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for UFPT is above the industry average of 7.89%.
The 3 year average ROIC (11.64%) for UFPT is below the current ROIC(13.23%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.88% | ||
| ROE | 17.6% | ||
| ROIC | 13.23% |
ROA(3y)10.52%
ROA(5y)8.58%
ROE(3y)16.84%
ROE(5y)13.25%
ROIC(3y)11.64%
ROIC(5y)9.67%
1.3 Margins
UFPT has a better Profit Margin (11.59%) than 88.24% of its industry peers.
UFPT's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 16.57%, UFPT belongs to the best of the industry, outperforming 87.70% of the companies in the same industry.
UFPT's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 28.99%, UFPT is doing worse than 75.40% of the companies in the same industry.
UFPT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.57% | ||
| PM (TTM) | 11.59% | ||
| GM | 28.99% |
OM growth 3Y16.51%
OM growth 5Y5.87%
PM growth 3Y14.91%
PM growth 5Y3.22%
GM growth 3Y5.49%
GM growth 5Y1.33%
2. Health
2.1 Basic Checks
UFPT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
UFPT has more shares outstanding than it did 1 year ago.
UFPT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, UFPT has a worse debt to assets ratio.
2.2 Solvency
UFPT has an Altman-Z score of 6.29. This indicates that UFPT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.29, UFPT belongs to the best of the industry, outperforming 82.89% of the companies in the same industry.
The Debt to FCF ratio of UFPT is 3.10, which is a good value as it means it would take UFPT, 3.10 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.10, UFPT belongs to the top of the industry, outperforming 88.24% of the companies in the same industry.
A Debt/Equity ratio of 0.47 indicates that UFPT is not too dependend on debt financing.
UFPT's Debt to Equity ratio of 0.47 is in line compared to the rest of the industry. UFPT outperforms 43.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 3.1 | ||
| Altman-Z | 6.29 |
ROIC/WACC1.51
WACC8.76%
2.3 Liquidity
UFPT has a Current Ratio of 2.58. This indicates that UFPT is financially healthy and has no problem in meeting its short term obligations.
UFPT has a Current ratio of 2.58. This is comparable to the rest of the industry: UFPT outperforms 49.73% of its industry peers.
UFPT has a Quick Ratio of 1.45. This is a normal value and indicates that UFPT is financially healthy and should not expect problems in meeting its short term obligations.
UFPT has a worse Quick ratio (1.45) than 60.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.58 | ||
| Quick Ratio | 1.45 |
3. Growth
3.1 Past
UFPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.35%, which is quite impressive.
The Earnings Per Share has been growing by 23.55% on average over the past years. This is a very strong growth
Looking at the last year, UFPT shows a very strong growth in Revenue. The Revenue has grown by 34.43%.
UFPT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.52% yearly.
EPS 1Y (TTM)31.35%
EPS 3Y53.29%
EPS 5Y23.55%
EPS Q2Q%34.76%
Revenue 1Y (TTM)34.43%
Revenue growth 3Y34.72%
Revenue growth 5Y20.52%
Sales Q2Q%41.08%
3.2 Future
UFPT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.28% yearly.
Based on estimates for the next years, UFPT will show a quite strong growth in Revenue. The Revenue will grow by 9.93% on average per year.
EPS Next Y16.76%
EPS Next 2Y14.6%
EPS Next 3Y14.28%
EPS Next 5YN/A
Revenue Next Year20.35%
Revenue Next 2Y12.73%
Revenue Next 3Y9.93%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
UFPT is valuated quite expensively with a Price/Earnings ratio of 30.49.
Based on the Price/Earnings ratio, UFPT is valued a bit cheaper than 74.33% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.28. UFPT is around the same levels.
UFPT is valuated rather expensively with a Price/Forward Earnings ratio of 24.96.
73.26% of the companies in the same industry are more expensive than UFPT, based on the Price/Forward Earnings ratio.
UFPT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.76.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.49 | ||
| Fwd PE | 24.96 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, UFPT is valued a bit cheaper than 75.40% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of UFPT indicates a rather cheap valuation: UFPT is cheaper than 80.75% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 32.55 | ||
| EV/EBITDA | 19.28 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
UFPT has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as UFPT's earnings are expected to grow with 14.28% in the coming years.
PEG (NY)1.82
PEG (5Y)1.29
EPS Next 2Y14.6%
EPS Next 3Y14.28%
5. Dividend
5.1 Amount
UFPT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:UFPT (7/3/2025, 11:15:00 AM)
249.135
+3.26 (+1.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners110.86%
Inst Owner Change7.11%
Ins Owners3.69%
Ins Owner Change4.24%
Market Cap1.92B
Analysts78
Price Target317.22 (27.33%)
Short Float %17.27%
Short Ratio6.67
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.07%
Min EPS beat(2)3.81%
Max EPS beat(2)8.33%
EPS beat(4)4
Avg EPS beat(4)9.7%
Min EPS beat(4)3.81%
Max EPS beat(4)14.29%
EPS beat(8)7
Avg EPS beat(8)15.09%
EPS beat(12)11
Avg EPS beat(12)31.68%
EPS beat(16)14
Avg EPS beat(16)26.54%
Revenue beat(2)1
Avg Revenue beat(2)1.69%
Min Revenue beat(2)-0.3%
Max Revenue beat(2)3.67%
Revenue beat(4)3
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-0.3%
Max Revenue beat(4)7.43%
Revenue beat(8)6
Avg Revenue beat(8)2.62%
Revenue beat(12)10
Avg Revenue beat(12)5.5%
Revenue beat(16)14
Avg Revenue beat(16)5.64%
PT rev (1m)-18.37%
PT rev (3m)-18.37%
EPS NQ rev (1m)3.69%
EPS NQ rev (3m)-0.08%
EPS NY rev (1m)2.39%
EPS NY rev (3m)0.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.45%
Revenue NY rev (1m)0.41%
Revenue NY rev (3m)2.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.49 | ||
| Fwd PE | 24.96 | ||
| P/S | 3.51 | ||
| P/FCF | 32.55 | ||
| P/OCF | 27.54 | ||
| P/B | 5.33 | ||
| P/tB | 69.98 | ||
| EV/EBITDA | 19.28 |
EPS(TTM)8.17
EY3.28%
EPS(NY)9.98
Fwd EY4.01%
FCF(TTM)7.65
FCFY3.07%
OCF(TTM)9.05
OCFY3.63%
SpS71.02
BVpS46.78
TBVpS3.56
PEG (NY)1.82
PEG (5Y)1.29
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.88% | ||
| ROE | 17.6% | ||
| ROCE | 16.13% | ||
| ROIC | 13.23% | ||
| ROICexc | 13.57% | ||
| ROICexgc | 34.55% | ||
| OM | 16.57% | ||
| PM (TTM) | 11.59% | ||
| GM | 28.99% | ||
| FCFM | 10.78% |
ROA(3y)10.52%
ROA(5y)8.58%
ROE(3y)16.84%
ROE(5y)13.25%
ROIC(3y)11.64%
ROIC(5y)9.67%
ROICexc(3y)11.86%
ROICexc(5y)10.07%
ROICexgc(3y)27.75%
ROICexgc(5y)22.85%
ROCE(3y)14.19%
ROCE(5y)11.78%
ROICexcg growth 3Y28.55%
ROICexcg growth 5Y9.48%
ROICexc growth 3Y27.39%
ROICexc growth 5Y1.08%
OM growth 3Y16.51%
OM growth 5Y5.87%
PM growth 3Y14.91%
PM growth 5Y3.22%
GM growth 3Y5.49%
GM growth 5Y1.33%
F-Score4
Asset Turnover0.85
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 3.1 | ||
| Debt/EBITDA | 1.59 | ||
| Cap/Depr | 65.69% | ||
| Cap/Sales | 1.96% | ||
| Interest Coverage | 9.01 | ||
| Cash Conversion | 65.12% | ||
| Profit Quality | 92.97% | ||
| Current Ratio | 2.58 | ||
| Quick Ratio | 1.45 | ||
| Altman-Z | 6.29 |
F-Score4
WACC8.76%
ROIC/WACC1.51
Cap/Depr(3y)91.16%
Cap/Depr(5y)78.11%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.7%
Profit Quality(3y)58.22%
Profit Quality(5y)76.97%
High Growth Momentum
Growth
EPS 1Y (TTM)31.35%
EPS 3Y53.29%
EPS 5Y23.55%
EPS Q2Q%34.76%
EPS Next Y16.76%
EPS Next 2Y14.6%
EPS Next 3Y14.28%
EPS Next 5YN/A
Revenue 1Y (TTM)34.43%
Revenue growth 3Y34.72%
Revenue growth 5Y20.52%
Sales Q2Q%41.08%
Revenue Next Year20.35%
Revenue Next 2Y12.73%
Revenue Next 3Y9.93%
Revenue Next 5YN/A
EBIT growth 1Y49.25%
EBIT growth 3Y56.96%
EBIT growth 5Y27.59%
EBIT Next Year48.19%
EBIT Next 3Y23.44%
EBIT Next 5YN/A
FCF growth 1Y552.02%
FCF growth 3Y85.71%
FCF growth 5Y17.47%
OCF growth 1Y207.54%
OCF growth 3Y67.03%
OCF growth 5Y16.35%